Project cooperation
Theriopharm can deliver solutions using IV and IP routes validated under murine sepsis models during preclinical tests
- Partner seeks Consortium/Coordinator
- Destination 3: HORIZON-HLTH-2027-01-DISEASE-08: Development of innovative antimicrobials against pathogens resistant to antimicrobials
Author
CEO at THERIOPHARM
Wavre, Belgium